Eltrombopag-Associated Cerebral Venous Thrombosis
- PMID: 33369923
- DOI: 10.1097/MJT.0000000000001044
Eltrombopag-Associated Cerebral Venous Thrombosis
Conflict of interest statement
The authors have no conflicts of interest to declare.
References
-
- Signal for thrombosis with eltrombopag and romiplostim: a disproportionality analysis of spontaneous reports within VigiBase®. Drug Saf. 2015;38:1179–1186.
-
- Guitton Z, Terriou L, Lega JC, et al. Risk of thrombosis with the antiphospholipid syndrome in systemic lupus erythematosus treated with thrombopoietin-receptor agonists. Rheumatology. 2018;57:1432–1438.
-
- Extensive cerebral venous sinus thrombosis following a dose increase in eltrombopag in a patient with idiopathic thrombocytopenic purpura. Platelets. 2014;25:144–146.
-
- Cerebral venous thrombosis in refractory idiopathic thrombocytopenia treated with eltrombopag. Ann Indian Acad Neurol. 2016;19:532–533.
-
- Bussel JB, Cheng G, Saleh MN, et al. Thromboembolic events observed in eltrombopag clinical trials in chronic immune thrombocytopenic purpura. ASH Annu Meet Abstr. 2009;114:2423.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical